- Home
- KNDI vs SRZN Comparison
KNDI vs SRZN Comparison
Compare KNDI & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNDI
- SRZN
- Stock Information
- Founded
- KNDI 2002
- SRZN 2015
- Country
- KNDI China
- SRZN United States
- Employees
- KNDI N/A
- SRZN N/A
- Industry
- KNDI Auto Manufacturing
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- KNDI Consumer Discretionary
- SRZN Health Care
- Exchange
- KNDI Nasdaq
- SRZN Nasdaq
- Market Cap
- KNDI 109.2M
- SRZN 97.3M
- IPO Year
- KNDI N/A
- SRZN N/A
- Fundamental
- Price
- KNDI $1.38
- SRZN $11.98
- Analyst Decision
- KNDI
- SRZN Strong Buy
- Analyst Count
- KNDI 0
- SRZN 2
- Target Price
- KNDI N/A
- SRZN $38.50
- AVG Volume (30 Days)
- KNDI 138.6K
- SRZN 12.2K
- Earning Date
- KNDI 11-17-2025
- SRZN 11-05-2025
- Dividend Yield
- KNDI N/A
- SRZN N/A
- EPS Growth
- KNDI N/A
- SRZN N/A
- EPS
- KNDI N/A
- SRZN N/A
- Revenue
- KNDI $104,035,613.00
- SRZN $12,621,000.00
- Revenue This Year
- KNDI N/A
- SRZN N/A
- Revenue Next Year
- KNDI N/A
- SRZN N/A
- P/E Ratio
- KNDI N/A
- SRZN N/A
- Revenue Growth
- KNDI N/A
- SRZN N/A
- 52 Week Low
- KNDI $0.89
- SRZN $5.90
- 52 Week High
- KNDI $2.07
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- KNDI 49.94
- SRZN 58.82
- Support Level
- KNDI $1.34
- SRZN $11.35
- Resistance Level
- KNDI $1.45
- SRZN $11.74
- Average True Range (ATR)
- KNDI 0.07
- SRZN 0.58
- MACD
- KNDI -0.02
- SRZN -0.10
- Stochastic Oscillator
- KNDI 19.05
- SRZN 34.11
About KNDI Kandi Technologies Group Inc
Kandi Technologies Group Inc is engaged in developing, manufacturing, and commercializing fully electric vehicle products and related technologies. Its products mainly consist of EV parts, EV products, and off-road vehicles, including All-Terrain Vehicles (ATVs), UTVs, go-karts, electric scooters, electric self-balancing scooters, and associated parts, and Lithium-ion cells, etc. The company generates maximum revenue from the sale of Off-road vehicles and associated parts. Geographically, it derives maximum revenue from the United States and other countries, followed by China.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).